Marianna Meschiari, Matteo Faltoni, Shaniko Kaleci, Giovanni Tassoni, Gabriella Orlando, Erica Franceschini, Giulia Burastero, Andrea Bedini, Lucia Serio, Emanuela Biagioni, Gabriele Melegari, Claudia Venturelli, Mario Sarti, Elisabetta Bertellini, Massimo Girardis, Cristina Mussini
BACKGROUND: We aim to investigate the efficacy of intravenous (IV) Fosfomycin as combination therapy for treatment of difficult-to-treat (DTT) multidrug-resistant (MDR) gram negative bacteria (GNB) acute and subacute infections and risk factors associated with 90-day mortality. METHODS: A retrospective, observational, monocentric study enrolled patients treated with IV Fosfomycin in combination regimens (>/= 72 h) for proven DTT-MDR-GNB based infection . Multivariate regression analysis identified independent risk factors for 90-day mortality...
March 5, 2024: International Journal of Antimicrobial Agents